Abbott Laboratories ABT
NYSE ABT
$102.00 -1.36 (-1.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Abbott Laboratories (ABT) Free Cash Flow (QoQ) (2009 - 2026)

Analysis

Abbott Laboratories (ABT) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.00 Bn 17.59 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.36%
Mar 31, 2026 -65.12%
Dec 31, 2025 14.62%
Sep 30, 2025 48.28%
Jun 30, 2025 65.59%
Mar 31, 2025 -56.56%
Dec 31, 2024 -0.05%
Sep 30, 2024 50.60%
Jun 30, 2024 127.59%
Mar 31, 2024 -72.54%
Dec 31, 2023 73.35%
Sep 30, 2023 89.22%
Jun 30, 2023 -8.78%
Mar 31, 2023 -55.54%
Dec 31, 2022 -25.81%
Sep 30, 2022 13.88%
Jun 30, 2022 16.46%
Mar 31, 2022 -28.90%
Dec 31, 2021 9.51%
Sep 30, 2021 30.61%